Aqr Capital Management LLC Sarepta Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $133,147 - $160,543	-1,299 Reduced 13.36%	8,422 $1.02 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $194,605 - $287,500	1,829 Added 23.18%	9,721 $1.11 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $595,406 - $790,245	5,066 Added 179.26%	7,892 $1.09 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $9,581 - $12,552	95 Added 3.48%	2,826 $366,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $206,764 - $325,644	2,731 New	2,731 $302,000
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $349,256 - $816,704	-4,834 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $22,600 - $32,173	-180 Reduced 3.59%	4,834 $824,000
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $401,444 - $544,249	3,158 Added 170.15%	5,014 $704,000
Q2 2020 Aug 17, 2020	SELL	$93.0 - $171.7 $263,748 - $486,941	-2,836 Reduced 60.44%	1,856 $298,000
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $98,032 - $156,651	-1,190 Reduced 20.23%	4,692 $459,000
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $134,233 - $237,807	-1,754 Reduced 22.97%	5,882 $759,000
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $639,563 - $1.38 Million	-8,784 Reduced 53.5%	7,636 $575,000
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $556,224 - $753,216	-4,957 Reduced 23.19%	16,420 $2.5 Million
Q1 2019 May 14, 2019	BUY	$106.67 - $151.68 $127,577 - $181,409	1,196 Added 5.93%	21,377 $2.55 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $529,128 - $808,808	-5,437 Reduced 21.22%	20,181 $2.2 Million
Q3 2018 Nov 15, 2018	SELL	$115.31 - $161.51 $5.22 Million - $7.31 Million	-45,231 Reduced 63.84%	25,618 $4.14 Million
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $1.25 Million - $2.68 Million	-17,427 Reduced 19.74%	70,849 $9.37 Million
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $873,827 - $1.33 Million	16,176 Added 22.44%	88,276 $6.54 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $446,291 - $531,634	-9,368 Reduced 11.5%	72,100 $4.01 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $2.91 Million - $3.84 Million	81,468	81,468 $3.7 Million

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.29 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.12 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$779 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$543 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$532 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account